Moderna’s mRNA Mpox Vaccine Beats Licensed Rivals In Early Test
The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of mpox lesions in infected animals compared to Bavarian Nordic’s licensed vaccine, Jynneos.
King Pie
Delete Comment
Are you sure that you want to delete this comment ?